Literature DB >> 14641550

Importance of P-glycoprotein for drug disposition in humans.

M F Fromm1.   

Abstract

The ATP-binding cassette transporter P-glycoprotein is now recognized as an important determinant for disposition of multiple drugs. The use of P-glycoprotein-expressing cell lines, the generation of P-glycoprotein knockout mice as well as studies in animals and humans contributed to a better understanding on the role of active transport processes for drug disposition. P-glycoprotein is located in tissues with excretory function such as intestine, liver and kidney. Moreover, due to its expression in important blood-tissue barriers (blood-brain and blood-testis barriers), in lymphocytes and in placenta it limits tissue penetration of its substrates. Induction and inhibition of P-glycoprotein have now been identified as important underlying mechanisms of drug interactions in humans. Using selected examples, this review summarizes currently available data on the impact of P-glycoprotein for bioavailability of drugs, drug interactions and drug effects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14641550     DOI: 10.1046/j.1365-2362.33.s2.4.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  33 in total

1.  Trabectedin (ET-743, Yondelis) is a substrate for P-glycoprotein, but only high expression of P-glycoprotein confers the multidrug resistance phenotype.

Authors:  Jan-Hendrik Beumer; Tessa Buckle; Mariet Ouwehand; Niels E F Franke; Luis Lopez-Lazaro; Jan H M Schellens; Jos H Beijnen; Olaf van Tellingen
Journal:  Invest New Drugs       Date:  2007-02       Impact factor: 3.850

2.  Effect of Phoneutria nigriventer venom on the expression of junctional protein and P-gp efflux pump function in the blood-brain barrier.

Authors:  Catarina Rapôso; Paulo Alexandre Miranda Odorissi; Alexandre L R Oliveira; Hiroshi Aoyama; Carmen Verissima Ferreira; Liana Verinaud; Karina Fontana; Roberta R Ruela-de-Sousa; Maria Alice da Cruz-Höfling
Journal:  Neurochem Res       Date:  2012-06-09       Impact factor: 3.996

Review 3.  Drug transporters in tissues and cells relevant to sexual transmission of HIV: Implications for drug delivery.

Authors:  Minlu Hu; Sravan Kumar Patel; Tian Zhou; Lisa C Rohan
Journal:  J Control Release       Date:  2015-08-13       Impact factor: 9.776

Review 4.  Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.

Authors:  Christine E Staatz; Lucy K Goodman; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2010-03       Impact factor: 6.447

Review 5.  Efflux transporters as a novel herbivore countermechanism to plant chemical defenses.

Authors:  Jennifer S Sorensen; M Denise Dearing
Journal:  J Chem Ecol       Date:  2006-05-23       Impact factor: 2.626

Review 6.  Blood-brain barrier active efflux transporters: ATP-binding cassette gene family.

Authors:  Wolfgang Löscher; Heidrun Potschka
Journal:  NeuroRx       Date:  2005-01

7.  Effects of budesonide on P-glycoprotein expression in intestinal cell lines.

Authors:  A Maier; C Zimmermann; C Beglinger; J Drewe; H Gutmann
Journal:  Br J Pharmacol       Date:  2006-12-18       Impact factor: 8.739

Review 8.  On a biophysical and mathematical model of Pgp-mediated multidrug resistance: understanding the "space-time" dimension of MDR.

Authors:  Vasiliki Panagiotopoulou; Giles Richardson; Oliver E Jensen; Cyril Rauch
Journal:  Eur Biophys J       Date:  2009-11-04       Impact factor: 1.733

9.  The different effects of itraconazole on the pharmacokinetics of fexofenadine enantiomers.

Authors:  Tomonori Tateishi; Masatomo Miura; Toshio Suzuki; Tsukasa Uno
Journal:  Br J Clin Pharmacol       Date:  2008-02-20       Impact factor: 4.335

10.  Mechanisms of the penetration of blood-borne substances into the brain.

Authors:  Masaki Ueno
Journal:  Curr Neuropharmacol       Date:  2009-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.